Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress

ATHE Stock  USD 3.34  0.38  10.22%   
About 61% of Alterity Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Alterity Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
MELBOURNE, Australia and SAN FRANCISCO, Dec. 04, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying

Read at benzinga.com
benzinga news
  

Alterity Therapeutics Fundamental Analysis

We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Alterity Therapeutics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Alterity Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.

Peers

Alterity Therapeutics Related Equities

ARTLArtelo Biosciences   1.74   
0%
16.0%
ANEBAnebulo Pharmaceuticals   0.61   
5.0%
0%
SRZNSurrozen   1.08   
10.0%
0%
TARAProtara Therapeutics   1.17   
11.0%
0%
PMVPPmv Pharmaceuticals   1.95   
18.0%
0%
HCWBHCW Biologics   2.44   
23.0%
0%
MNPRMonopar Therapeutics   2.78   
26.0%
0%
NBYNovaBay Pharmaceuticals   3.03   
28.0%
0%
ANTXAN2 Therapeutics   3.70   
35.0%
0%
ATXIAvenue Therapeutics   4.62   
43.0%
0%
ADILAdial Pharmaceuticals   4.67   
44.0%
0%
RNAZTranscode Therapeutics   4.99   
47.0%
0%
QNRXQuoin Pharmaceuticals   6.06   
57.0%
0%
RVPHReviva Pharmaceuticals   6.50   
61.0%
0%
ADTXAditxt   10.53   
100.0%
0%

Complementary Tools for Alterity Stock analysis

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated